FDA Approved Medical Products for:

Acute promyelocytic leukemia

The table(s) below may not be an exhaustive list of drugs or products used to treat this condition. There may be other products available that are not considered orphan products.

Generic Name Arsenic trioxide
Trade Name
(Manufacturer Name)
Trisenox®
(Cephalon® Oncology)
Indication
The FDA has approved this product to be used in this manner.
For induction of remission and consolidation in patients with acute promyelocytic leukemia (APL) who are refractory to, or have relapsed from, retinoid and anthracycline chemotherapy, and whose APL is characterized by the presence of the t(15;17) transloc
More Information about this product Drug Information Portal
Medline Plus Health Information

Generic Name Tretinoin
Trade Name
(Manufacturer Name)
Vesanoid®
(Roche Pharmaceuticals)
Indication
The FDA has approved this product to be used in this manner.
Induction of remission in patients with acute promyelocytic leukemia who are refractory to or unable to tolerate anthracycline based cytotoxic chemotherapeutic regimens.
More Information about this product Drug Information Portal
Medline Plus Health Information